Advertisement

Topics

PellePharm Announces Topline Results from Phase 2 Study of Topical Patidegib in Gorlin Syndrome ...

02:06 EDT 31 Jul 2017 | BioMedReports - Blog
-- Company on Track for a Phase 3 Clinical Trial in 1H18 --

Read more...

Original Article: PellePharm Announces Topline Results from Phase 2 Study of Topical Patidegib in Gorlin Syndrome ...

NEXT ARTICLE

More From BioPortfolio on "PellePharm Announces Topline Results from Phase 2 Study of Topical Patidegib in Gorlin Syndrome ..."

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...